Sens. to Sebelius: Support the NIH

Today on Capitol Hill, Department of Health and Human Services Secretary Kathleen Sebelius caught a little guff from Senators Tom Harkin (D-IA) and Arlen Specter (D-PA) about the paltry increase -- just about $442 million -- that HHS is proposing for the National Institutes of Health's 2010 budget. "I would urge you to take another look at that figure," Specter said to Sebelius at a Senate subcommittee linkurl:hearing.;http://www.senate.gov/fplayers/CommPlayer/commFlashPlayer.cfm?fn=appropsA060

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
Today on Capitol Hill, Department of Health and Human Services Secretary Kathleen Sebelius caught a little guff from Senators Tom Harkin (D-IA) and Arlen Specter (D-PA) about the paltry increase -- just about $442 million -- that HHS is proposing for the National Institutes of Health's 2010 budget. "I would urge you to take another look at that figure," Specter said to Sebelius at a Senate subcommittee linkurl:hearing.;http://www.senate.gov/fplayers/CommPlayer/commFlashPlayer.cfm?fn=appropsA060909p&st=35 "We are in jeopardy of losing a generation of young research scientists. And I think we have to maintain the growth rate." Sebelius responded that, in terms of keeping the NIH's funding healthy, she too wants to "make sure we don't reach a cliff and fall off the edge of the cliff." "I share the concern that we continue to invest in science and research," Sebelius said. But she maintained that the $10 billion that NIH scored in the stimulus bill would be enough to carry the agency through some lean budget years. "In putting together the 2010 budget there was a recognition that the Recovery Act funds will fund 2010 and some of the 2011 strategies" for sustaining this overall investment, she said. To this Specter replied that "the stimulus package and that $10 billion," which he had a big hand in securing for the agency, "ought not to be looked at for the regular funding." "We were looking for that to stimulate the economy and for jobs," Specter continued. "It was not the generalization that the stimulus would be used in place of future years' funding. We'd like to maintain NIH funding on its own." Then Harking, the subcommittee chairman, joined in. "I am concerned about the 'cliff,' and the baseline, and what happens to that baseline funding," he said. "To only put in $442 million doesn't do much for getting our baseline up." With Specter and Harkin sitting on the Senate subcommittee responsible for negotiating HHS's federal funding, the NIH may see more money in 2010 than HHS has asked for at first blush. And with record numbers of researchers applying for the NIH's stimulus-cash-fueled Challenge Grants and more likely to belly up to the trough, the agency will likely need it. "[Specter's] going to be dogged on this," said Harkin before adjourning the meeting, "and I am going to be joining with him on it."
**__Related stories:__***linkurl:Science scores in 2010 US budget;http://www.the-scientist.com/blog/display/55681/
[7th May 2009]*linkurl:Life science scores in 2010 budget;http://www.the-scientist.com/blog/display/55483/
[26th February 2009]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Bob Grant

    From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide